SAT-3247

N/A

Report date: 2026/04/16 20:00:17
NMEFirst In Class

Base Information

Drug NameSAT-3247
Drug Alias NameSAT-3247
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitorsAP2-associated protein kinase 1 inhibitors
TargetsProtein kinasesAP2-associated protein kinase 1
Therapy Area/IndicationsNeuromuscular DiseasesMuscular Dystrophy, DuchenneMuscular Dystrophies +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSatellos Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesSatellos Bioscience Inc
Inactive CompaniesN/A
Active IndicationsNeuromuscular DiseasesMuscular Dystrophy, DuchenneMuscular Dystrophies +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A